Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026)

Azenta (AZTA) recorded quarterly Liabilities and Shareholders Equity of $1.9 billion in Q1 2026, down 8.22% quarter-over-quarter from $2.1 billion in Q4 2025, and down 6.4% on a YoY basis from $2.0 billion in Q1 2025.

Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Azenta's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 6.4% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $8.1 billion (down 5.22% YoY), while the FY2025 annual figure was $2.1 billion, changed N/A from the prior year.
  • Liabilities and Shareholders Equity was $1.9 billion for Q1 2026 at Azenta, down from $2.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.2 billion in Q1 2022 to a low of $1.9 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 149.93% in 2022, then dropped 27.67% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.3 billion in 2022, then dropped by 14.22% to $2.8 billion in 2023, then decreased by 27.67% to $2.0 billion in 2024, then increased by 1.55% to $2.1 billion in 2025, then decreased by 8.22% to $1.9 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $1.9 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Azenta 1.06 Bn 682.62 Mn 62.04 Mn 1.90 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.90 Bn
Dec 31, 2025 2.07 Bn
Sep 30, 2025 2.06 Bn
Jun 30, 2025 2.02 Bn
Mar 31, 2025 2.03 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2.10 Bn
Jun 30, 2024 2.32 Bn
Mar 31, 2024 2.56 Bn
Dec 31, 2023 2.82 Bn
Sep 30, 2023 2.89 Bn
Jun 30, 2023 3.07 Bn
Mar 31, 2023 3.25 Bn
Dec 31, 2022 3.29 Bn
Sep 30, 2022 3.72 Bn
Jun 30, 2022 3.72 Bn
Mar 31, 2022 4.16 Bn
Dec 31, 2021 1.85 Bn
Sep 30, 2021 1.82 Bn
Jun 30, 2021 1.76 Bn